GOOD

BIOSTATISTICAL

REVIEW 
STANDARDS 

​ARZU KANIK, PROF.DR. PHD, SCIENTIFIC DIRECTOR, MEDICRES NEW YORK * Alvaro Atallah  MD, MSCE,Internal Medicine & Evidence-Based Medicine,  Universidade Federal de São Paulo, BRASIL * Brahmajee Nallamothu MD,Associate Professor,Division of Cardiovascular Diseases,Department of Internal Medicine Investigator,Center for Clinical Management Research University of Michigan * Christiane Druml Ph.D. Vice Rector for Clinical Affairs Medical University of Vienna * David Madigan Executive Vice President for Arts and Science and Professor of Statistics at Columbia University in New York City * David Moher Associate  Professor,School of Epidemiology ,Public Health and Preventive Medicine,University of Ottawa * Delia Wolf  Regulatory Affairs & Reseach Compliance at Harvard School of Public Health,Boston * Denise Esserman Ph.D.,  Associate Professor of Public Health (Biostatistics), School of Public ,Health: Yale Center for Analytical Sciences (YCAS) * Doug Altman DSc. Director, Centre for Statistics in Medicine, University of Oxford * Fikret Ikiz Emeritus Professor, Department of Biostatistics & Bioinformatics , Ege University * Gui- Shuang Ying MD, Ph.D, University of Pennsylvania, School of Medicine, Clinical Trial Coordinating Center, Department of Ophthalmology, Philadelphia, USA * Han Liu Assistant Professor, Department of Operations Research and Financial Engineering Princeton University * Hans Karle MD,DMSc,Dhc,FRCP,Herlev University Hospital,University of Copenhagen * Iain Hrynaszkiewicz BioMed Central, London, United Kingdom * Iveta Simera PhD, Head of Programme Development, Equator Network, Centre for Statistics in Medicine, Oxford UK * Ivonne Solis-Trapala PhD,MRC Fellow in Biostatistics, School of Health and Medicine, Lancaster,United Kingdom * Prof. Jonas Ranstam, PhD, Department of Clinical Sciences, Sweden * Francesca Martinelli, European Organization for Research Treatment of Cancer, Italy * John Overbeke MD, PhD, Representative MedicReS , Past President World Association of Medical Editors, WAME, Netherland * Judith D. Goldberg ScD is Professor of Biostatistics at New York University School of Medicine * Liz WAGER PhD, Chair of Committee on Publication Ethics (COPE),United Kingdom * Marusic Ana  MD, PhD, Chair of the Department of Research in Biomedicine and Health, University of Split School of Medicine, Croatia * Michael Berkowitz MD,Professor of Modern Jewish History ,Dept of Hebrew&Jewish Studies ,Faculty  of Arts&Humanities ,London,UK * Michael FW Festing PhD, DSc,Biostatistics ,Cstat, London, UK * Dr. Justine Davies, Executive Editor Lancet, UK * Joseph Levy, TEVA Pharmaceutical Industries LTD, Israel * Michael Schemper PhD, Medical University of Vienna, Core Unit of Medical Statistics and Informatics, Section of Clinical Biometrics, Vienna, AUSTRIA * Monica Gaidhane MD, MPH, Clinical Research Manager at Weill Cornell Medical,Newyork,US * Shelley Hurwitz Director of Biostatistics in the Center for Clinical Investigation at Brigham and Women's Hospital, a teaching hospital of Harvard Medical School,Harvard Catalyst, Boston * Shing Lee PhD, Assistant Professor, Biostatistics at the Columbia University Medical Center,New York * Siegfried KASPER MD, PhD, Professor and Chairman, Department of Biological Psychiatry, Medical University of Vienna, AUSTRIA * Suzanne Pozsonyi Clinical Research Specialist, SynCon International Clinical Research, Consultancy , Hungary * Trish Groves Deputy Editor,BMJ Publishing Group,Medicine,London * Z. Nazan Alparslan PhD,University of Cukurova, Medical Faculty, Department of Biostatistics . 

WHY MEDICRES ?


GOOD

BIOSTATISTICAL CONSULTANCY STANDARDS

"It has thus become increasingly important that the teaching of good medical research methods be expanded to scientists and institutions in low and middle-income countries that face major health challenges in the decades ahead.There is a critical shortage of technical skills in these countries--and for that matter in first-world nations--of researchers who are imbued with a deep understanding of the fundamental ideas underlying the successful design and analysis of medical and public health research studies.Such ideas must necessarily incorporate the latest algorithms and statistical approaches afforded by the computing and communication revolutions,in addition to the essential ethics of experimentation, policy advising and reporting to our communities regarding the public’s health."

Nicholas P. JEWELL, PhD, MedicReS Scientific Board Member

MEDICRES SCIENTIFIC CONTRIBUTERS 

  • 2007 - Founded in Vienna
  • 2008 - Good Medical Research
  • 2011 - GBP - Good Biostatistical Practice
  • 2014 - New York World Congress
  • 2016 - MedicReS International Scientific Network " MedicReS Club"
  • 2016 - MedicreS Education Program BeGMR
  • 2016 - A smart and an interactive tool
    for creating "Good Medical Research"

GOOD 
BIOSTATISTICAL

PRACTICE